多发性-话题@MedSci

#多发性#

905篇内容 | 3063人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890073, encodeId=337b18900e399, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛, objectType=article, longId=183118, objectId=b4f118311887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4f118311887, replyNumber=0, likeNumber=80, createdTime=2019-12-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4f118311887, moduleTitle=英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4f118311887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890072, encodeId=f72418900e283, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 共识建议：多发性硬化的诊断和治疗（更新版）, objectType=article, longId=182409, objectId=05ab1824095b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05ab1824095b, replyNumber=0, likeNumber=18, createdTime=2020-10-15, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05ab1824095b, moduleTitle=2019 共识建议：多发性硬化的诊断和治疗（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05ab1824095b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890088, encodeId=3c791890088fa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：多发性硬化症患者多重死亡原因分析, objectType=article, longId=186291, objectId=99f918629103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99f918629103, replyNumber=0, likeNumber=81, createdTime=2020-06-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99f918629103, moduleTitle=Neurology：多发性硬化症患者多重死亡原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99f918629103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890026, encodeId=9d08189002615, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 实践指南：多发性硬化病变核磁共振检查评估, objectType=article, longId=172208, objectId=9c7e1e22087b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c7e1e22087b, replyNumber=0, likeNumber=18, createdTime=2020-03-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c7e1e22087b, moduleTitle=2019 实践指南：多发性硬化病变核磁共振检查评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c7e1e22087b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890035, encodeId=699b189003544, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA接受了赛诺菲的申请，要求批准isatuximab用于复发难治多发性骨髓瘤患者, objectType=article, longId=175274, objectId=fe9b1e5274cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe9b1e5274cc, replyNumber=0, likeNumber=66, createdTime=2020-05-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe9b1e5274cc, moduleTitle=FDA接受了赛诺菲的申请，要求批准isatuximab用于复发难治多发性骨髓瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe9b1e5274cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890110, encodeId=7a1118901102b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：多发性硬化妇女妊娠相关的复发和母乳喂养, objectType=article, longId=192323, objectId=aad2192323c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aad2192323c8, replyNumber=0, likeNumber=65, createdTime=2021-02-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aad2192323c8, moduleTitle=Neurology：多发性硬化妇女妊娠相关的复发和母乳喂养, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aad2192323c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890121, encodeId=59a1189012145, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=III期临床：赛诺菲的CD38单抗Sarclisa显着降低了多发性骨髓瘤复发患者的死亡风险, objectType=article, longId=194121, objectId=ec9d1941215a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec9d1941215a, replyNumber=0, likeNumber=59, createdTime=2021-01-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec9d1941215a, moduleTitle=III期临床：赛诺菲的CD38单抗Sarclisa显着降低了多发性骨髓瘤复发患者的死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec9d1941215a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890122, encodeId=35fd189012211, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市, objectType=article, longId=194138, objectId=e8bf19413837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8bf19413837, replyNumber=0, likeNumber=67, createdTime=2020-05-19, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8bf19413837, moduleTitle=NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8bf19413837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890015, encodeId=034e189001534, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 ASCO：Janssen抗CD38单抗Darzalex治疗多发性骨髓瘤III期数据喜人, objectType=article, longId=167615, objectId=3d4d16e61584, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d4d16e61584, replyNumber=0, likeNumber=71, createdTime=2020-02-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d4d16e61584, moduleTitle=2019 ASCO：Janssen抗CD38单抗Darzalex治疗多发性骨髓瘤III期数据喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d4d16e61584)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890084, encodeId=25de1890084d2, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定, objectType=article, longId=185458, objectId=677c185458b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677c185458b1, replyNumber=0, likeNumber=65, createdTime=2020-02-09, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677c185458b1, moduleTitle=多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677c185458b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890074, encodeId=361a18900e4e9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素, objectType=article, longId=183123, objectId=216a18312397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=216a18312397, replyNumber=0, likeNumber=78, createdTime=2020-06-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=216a18312397, moduleTitle=Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=216a18312397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890023, encodeId=43ea189002358, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=【2019EHA】蔡真教授：高龄及高危遗传学特征的多发性骨髓瘤重要进展盘点, objectType=article, longId=169075, objectId=76bf1690e575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76bf1690e575, replyNumber=0, likeNumber=60, createdTime=2020-02-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76bf1690e575, moduleTitle=【2019EHA】蔡真教授：高龄及高危遗传学特征的多发性骨髓瘤重要进展盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76bf1690e575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890117, encodeId=ef63189011e7f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：多发性骨髓瘤粒细胞髓系抑制细胞的免疫基因组学鉴定及特征, objectType=article, longId=193445, objectId=598e1934458f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=598e1934458f, replyNumber=0, likeNumber=91, createdTime=2020-11-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=598e1934458f, moduleTitle=Blood：多发性骨髓瘤粒细胞髓系抑制细胞的免疫基因组学鉴定及特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=598e1934458f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890096, encodeId=4e211890096ab, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA批准赛诺菲靶向CD38的单抗Sarclisa，用于治疗复发或难治的多发性骨髓瘤, objectType=article, longId=189424, objectId=bef9189424e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef9189424e7, replyNumber=0, likeNumber=80, createdTime=2020-05-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef9189424e7, moduleTitle=FDA批准赛诺菲靶向CD38的单抗Sarclisa，用于治疗复发或难治的多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bef9189424e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890014, encodeId=893d1890014ad, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=2019 专家共识声明：多发性骨髓瘤首次复发的正确评估, objectType=article, longId=167556, objectId=c10016e556e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c10016e556e3, replyNumber=0, likeNumber=20, createdTime=2020-01-13, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c10016e556e3, moduleTitle=2019 专家共识声明：多发性骨髓瘤首次复发的正确评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c10016e556e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890033, encodeId=e4ac1890033e2, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案, objectType=article, longId=175081, objectId=1ce51e50810d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ce51e50810d, replyNumber=0, likeNumber=72, createdTime=2020-04-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ce51e50810d, moduleTitle=苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ce51e50810d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890053, encodeId=1077189005339, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=诺华的CD20单抗Arzerra治疗多发性硬化症的两项III期试验成功, objectType=article, longId=178542, objectId=bc501e854207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc501e854207, replyNumber=0, likeNumber=0, createdTime=2020-03-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc501e854207, moduleTitle=诺华的CD20单抗Arzerra治疗多发性硬化症的两项III期试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc501e854207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890064, encodeId=6baf189006470, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多种皮瓣联合应用修复上唇部多发性基底细胞癌一例, objectType=article, longId=179982, objectId=bd271e9982d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd271e9982d1, replyNumber=0, likeNumber=86, createdTime=2020-08-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd271e9982d1, moduleTitle=多种皮瓣联合应用修复上唇部多发性基底细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd271e9982d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890076, encodeId=286a18900e61b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=FDA批准了诺华多发性硬化症药物Gilenya的仿制药, objectType=article, longId=184300, objectId=0ae61843008b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae61843008b, replyNumber=0, likeNumber=71, createdTime=2020-01-30, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae61843008b, moduleTitle=FDA批准了诺华多发性硬化症药物Gilenya的仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae61843008b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890044, encodeId=b31a1890044da, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=妊娠期多发性牙龈瘤1例, objectType=article, longId=176323, objectId=d2101e6323ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2101e6323ad, replyNumber=0, likeNumber=80, createdTime=2019-12-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2101e6323ad, moduleTitle=妊娠期多发性牙龈瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2101e6323ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

英国NICE更新指南，推荐将拜尔的大麻二酚药物Sativex用于治疗多发性硬化症患者的痉挛

2019-12-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 共识建议：多发性硬化的诊断和治疗（更新版）

2020-10-15

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：多发性硬化症患者多重死亡原因分析

2020-06-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 实践指南：多发性硬化病变核磁共振检查评估

2020-03-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA接受了赛诺菲的申请，要求批准isatuximab用于复发难治多发性骨髓瘤患者

2020-05-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：多发性硬化妇女妊娠相关的复发和母乳喂养

2021-02-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

III期临床：赛诺菲的CD38单抗Sarclisa显着降低了多发性骨髓瘤复发患者的死亡风险

2021-01-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

NMPA：多发性硬化的S1P靶向治疗药物西尼莫德批准上市

2020-05-19

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 ASCO：Janssen抗CD38单抗Darzalex治疗多发性骨髓瘤III期数据喜人

2020-02-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多靶标蛋白药物：美国FDA授予MP0250治疗多发性骨髓瘤的孤儿药认定

2020-02-09

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素

2020-06-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

【2019EHA】蔡真教授：高龄及高危遗传学特征的多发性骨髓瘤重要进展盘点

2020-02-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：多发性骨髓瘤粒细胞髓系抑制细胞的免疫基因组学鉴定及特征

2020-11-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA批准赛诺菲靶向CD38的单抗Sarclisa，用于治疗复发或难治的多发性骨髓瘤

2020-05-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

2019 专家共识声明：多发性骨髓瘤首次复发的正确评估

2020-01-13

jml2009 (审核中...)

前往app查看评论内容

#多发性#

苏格兰医药联盟积极推荐Darzalex作为多发性骨髓瘤的二线治疗方案

2020-04-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

诺华的CD20单抗Arzerra治疗多发性硬化症的两项III期试验成功

2020-03-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多种皮瓣联合应用修复上唇部多发性基底细胞癌一例

2020-08-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

FDA批准了诺华多发性硬化症药物Gilenya的仿制药

2020-01-30

jml2009 (审核中...)

前往app查看评论内容

#多发性#

妊娠期多发性牙龈瘤1例

2019-12-25

科室
- - 订阅+
  - 更多科室
工具
服务